OptimizeRx Corp

NAS:OPRXHealthcarenasdaq_composite

$9.14+0.66%LiveIn session · ≈ AED 33.57 · Market cap $172.16M · Next earnings Thu 5 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	55.7%	58.1%	62.4%	60.0%	64.5%	63.3%	—	—
Operating margin	−4.9%	0.6%	−19.7%	−36.9%	−14.9%	11.0%	11.0%	+0.0 pts
Net margin	−5.1%	0.6%	−18.3%	−24.6%	−21.8%	4.7%	4.7%	+0.0 pts
EBITDA margin	1.5%	3.8%	−15.1%	−29.8%	−9.7%	15.1%	—	—
Return on equity	−4.4%	0.3%	−9.1%	−13.9%	−17.2%	4.0%	4.0%	+0.0 pts
Return on assets	−3.7%	0.3%	−8.5%	−9.6%	−11.7%	2.9%	2.9%	+0.0 pts
Return on capital employed	−4.2%	0.3%	−9.7%	−16.0%	−9.0%	7.7%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.3×	0.3×	0.2×	0.2×	+0.0%
Debt / assets	0.7%	0.2%	0.2%	20.1%	19.4%	14.8%	—	—
Interest coverage	0.0×	0.0×	0.0×	−18.2×	−2.2×	2.3×	—	—
Current ratio	3.3×	12.3×	11.7×	3.0×	2.9×	3.0×	3.0×	+0.0%
Quick ratio	3.3×	12.3×	11.7×	3.0×	2.9×	3.0×	—	—
Cash ratio	1.0×	9.0×	2.2×	0.8×	0.7×	1.1×	1.1×	+0.0%
Asset turnover	0.7×	0.4×	0.5×	0.4×	0.5×	0.6×	—	—
Receivables turnover	2.4×	2.5×	2.8×	1.9×	2.4×	2.8×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.